T1D Fund

Boston, United States
Companies developing T1D products are funded through venture philanthropy.

About T1D Fund

T1D Fund is a Financial Services company based in Boston (United States). Companies developing T1D products are funded through venture philanthropy. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.

Company details

Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.

  • Headquarters Boston, United States
  • Sectors
    Financial Services
  • Website t1dfund.org

People of T1D Fund

2 people are tracked at T1D Fund (2 in team).

NameRoleGroup
Daniel Flicker
Senior AssociateTeam
Morgan Janes
AssociateTeam
Premium access

Complete people profiles for T1D Fund

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Top companies in Venture Capital Funds

3 companies that operate in the same segment as T1D Fund (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Venture capital firm investing in early-stage tech startups
1972Menlo Park, California, United States
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
1911Redwood City, California, United StatesUSD 691.23 K
Accel is recognized as a leading venture capital firm.
1983Palo Alto, California, United States
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about T1d Fund

Premium access

Complete news archive for T1D Fund

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about T1D Fund

T1D Fund is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Investments are directed by the T1D Fund toward companies advancing Type 1 Diabetes (T1D) products within the biotechnology sector. Operations are centered in Boston, United States, with a focus on venture philanthropy to support innovative treatments. The portfolio encompasses firms like Bigfoot Biomedical, Diasome Pharmaceuticals, and eGenesis Bio, where financial and strategic backing is provided to accelerate T1D solutions.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available